HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Paolo Fanizzi Selected Research

Type 2 Diabetes Mellitus (MODY)

5/2019NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Paolo Fanizzi Research Topics

Disease

20Neoplasms (Cancer)
11/2023 - 01/2011
6Breast Neoplasms (Breast Cancer)
05/2019 - 07/2010
5Neuroblastoma
01/2022 - 01/2014
3Disease Progression
05/2023 - 05/2019
3Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2020
2Adenocarcinoma
11/2023 - 01/2023
2Neoplasm Metastasis (Metastasis)
10/2023 - 07/2010
2Glioma (Gliomas)
04/2021 - 04/2021
2Infections
07/2019 - 04/2019
2Malaria
11/2012 - 03/2012
1Mitochondrial Diseases (Mitochondrial Disease)
03/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2023
1Osteoarthritis
11/2022
1Glioblastoma (Glioblastoma Multiforme)
04/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1Vibrio Infections
05/2019
1Type 2 Diabetes Mellitus (MODY)
05/2019
1Hyperglycemia
05/2019
1Carcinoma (Carcinomatosis)
05/2019
1Dehydration (Water Stress)
05/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Ovarian Epithelial Carcinoma
09/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2018
1Ototoxicity
05/2016
1Necrosis
01/2016
1Hypertrophy
01/2016
1Malignant Mesothelioma
01/2016
1Atrophy
02/2015

Drug/Important Bio-Agent (IBA)

13Cisplatin (Platino)FDA LinkGeneric
11/2023 - 10/2013
6PlatinumIBA
11/2023 - 01/2011
4Platinum Compounds (Compounds, Platinum)IBA
11/2023 - 02/2015
3Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2023 - 01/2022
3Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2019
3Pt(O,O'-acac)(gamma-acac)(DMS)IBA
04/2021 - 07/2010
3Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2019
2Anti-Bacterial Agents (Antibiotics)IBA
07/2019 - 05/2019
2acetyl acetonate (acetylacetonate)IBA
11/2014 - 01/2011
2Matrix Metalloproteinases (MMPs)IBA
01/2014 - 07/2010
1CholesterolIBA
03/2024
1Triglycerides (Triacylglycerol)IBA
03/2024
1Glucose (Dextrose)FDA LinkGeneric
03/2024
1Antiviral Agents (Antivirals)IBA
11/2023
1DNA (Deoxyribonucleic Acid)IBA
11/2023
1phenanthriplatinIBA
11/2023
1TubulinIBA
10/2023
1Antineoplastic Agents (Antineoplastics)IBA
10/2023
1CurcuminIBA
09/2023
1oleuropeinIBA
05/2023
1Quinic Acid (Quinate)IBA
05/2023
1Mannitol (Osmitrol)FDA LinkGeneric
05/2023
1Organometallic CompoundsIBA
01/2023
1Collagen Type II (Type II Collagen)IBA
11/2022
1PhenanthrolinesIBA
01/2022
1ethyl acetateIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1MetalsIBA
06/2019
1CarbohydratesIBA
05/2019
1LipidsIBA
05/2019
1Human Serum AlbuminFDA LinkGeneric
05/2019
1Protein CoronaIBA
05/2019
1Calcium Carbonate (Limestone)FDA Link
05/2019
1malic acid (malate)IBA
04/2019
1EnzymesIBA
01/2019
1CaspasesIBA
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
01/2019
1dactolisibIBA
01/2018
1Capsules (Microcapsules)IBA
06/2017
1ElementsIBA
02/2016
1Carisoprodol (Soma)FDA LinkGeneric
02/2015
1dimethyl sulfideIBA
11/2014
1platinum(II) 2,4-pentanedionateIBA
01/2014
1Metalloproteases (Metalloproteinases)IBA
01/2014
1TeaIBA
11/2012
1Antimalarials (Antimalarial Agents)IBA
03/2012
1CalciumIBA
01/2011

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2023 - 01/2016
3Therapeutics
11/2023 - 10/2020
1Nephrectomy
01/2016